AbbVie Depreciation & Amortization 2011-2026 | ABBV

Annual Depreciation & Amortization AbbVie

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
762 M	764 M	752 M	778 M	803 M	666 M	464 M	471 M	425 M	425 M	417 M	383 M	388 M	525 M	508 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
803 M	383 M	569 M

Quarterly Depreciation & Amortization AbbVie

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
192 M	186 M	181 M	191 M	184 M	183 M	196 M	190 M	179 M	-	181 M	203 M	198 M	-	223 M	201 M	206 M	-	175 M	149 M	115 M	-	114 M	114 M	118 M	-	115 M	119 M	115 M	-	111 M	110 M	103 M	-	96 M	108 M	103 M	-	102 M	104 M	90 M	-	94 M	103 M	89 M	-	97 M	100 M	92 M	-	93 M	119 M	140 M	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
223 M	89 M	140 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Aligos Therapeutics ALGS	930 K	$ 8.49	6.25 %	$ 83.9 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Esperion Therapeutics ESPR	105 K	$ 2.15	-0.69 %	$ 447 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 20.87	2.45 %	$ 976 M	USA
GT Biopharma GTBP	4 K	$ 0.37	-0.92 %	$ 2.04 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Halozyme Therapeutics HALO	11.4 M	$ 66.86	-1.42 %	$ 8.01 B	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Harmony Biosciences Holdings HRMY	23.8 M	$ 28.5	-1.35 %	$ 1.64 B	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	1.27 M	$ 1.43	2.14 %	$ 368 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.91	-0.26 %	$ 4.79 M	Israel
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.18	2.45 %	$ 447 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 23.96	-1.03 %	$ 3.05 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	3.38 M	$ 32.21	-0.09 %	$ 2.14 B	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.49	-0.34 %	$ 397 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Incyte Corporation INCY	93.3 M	$ 94.65	-1.48 %	$ 18.5 B	USA
Cidara Therapeutics CDTX	154 K	-	-	$ 1.41 B	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	5.38 M	$ 2.57	0.78 %	$ 16.1 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA